Expert Reviews present niche topics made accessible by pharmaceutical industry specialists with comprehensive references for further in-depth study. Subscribe now to our free monthly email alert which provides details of new titles published within the KeywordPharma knowledge library.
Use the navigation menus to explore further back into the database, or use the search tool to research throughout the site.
In this timely and comprehensive Expert Review, Emma D’Arcy of myPHID argues that the future of interactions between industry and the medical community will be about openly aligning aspirations and ambitions.
In this Expert Review, John Hammond examines how genetic analysis can be useful in designing drug regimens. It outlines where the best gains for drug safety can be made and how genotyping can help form part of the solution.
Mike Rea examines why strategic marketing is of pivotal consequence to the success or failure of a pharmaceutical brand, putting the case for earlier implementation of rigorous, externally triangulated assessment of strategic marketing plans.
This report by Liz Wager, FDAAA Legislation: Global Implications for Clinical Trial Reporting and Publication Planning, describes the new requirements for trial registration and the reporting of results, and explains what companies need to do now.
Joan Barnard, Rene Lai and Andrew Robson have delivered a line-by-line summary of all revisions, both major and minor, to the latest EFPIA codes, and offer insight into the likely implications for the pharmaceutical industry and its customers.
